These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 38372700)
21. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314 [TBL] [Abstract][Full Text] [Related]
22. RAS-related GTPases DIRAS1 and DIRAS2 induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells. Sutton MN; Yang H; Huang GY; Fu C; Pontikos M; Wang Y; Mao W; Pang L; Yang M; Liu J; Parker-Thornburg J; Lu Z; Bast RC Autophagy; 2018; 14(4):637-653. PubMed ID: 29368982 [TBL] [Abstract][Full Text] [Related]
23. RNAa and Vector-Mediated Overexpression of DIRAS1 Suppresses Tumor Growth and Migration in Renal Cell Carcinoma. Xu X; Li J; Wang S; Zheng X; Xie L Mol Ther Nucleic Acids; 2018 Sep; 12():845-853. PubMed ID: 30161023 [TBL] [Abstract][Full Text] [Related]
24. Epitranscriptomic profiling of N6-methyladenosine-related RNA methylation in rat cerebral cortex following traumatic brain injury. Yu J; Zhang Y; Ma H; Zeng R; Liu R; Wang P; Jin X; Zhao Y Mol Brain; 2020 Jan; 13(1):11. PubMed ID: 31992337 [TBL] [Abstract][Full Text] [Related]
25. FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and Myc. Wang A; Jin C; Wang Y; Yu J; Wang R; Tian X Mol Carcinog; 2023 Aug; 62(8):1228-1237. PubMed ID: 37306026 [TBL] [Abstract][Full Text] [Related]
26. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer. Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987 [TBL] [Abstract][Full Text] [Related]
27. Changes of N6-methyladenosine modulators promote breast cancer progression. Wu L; Wu D; Ning J; Liu W; Zhang D BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473 [TBL] [Abstract][Full Text] [Related]
28. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP. Ma Z; Li Q; Liu P; Dong W; Zuo Y Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897 [TBL] [Abstract][Full Text] [Related]
29. Increased m6A-RNA methylation and demethylase FTO suppression is associated with silica-induced pulmonary inflammation and fibrosis. Xu Y; Wang L; Qian R; Zhao M; Chen X; Sun D; Wang Y; Cheng W; Chen Y; He Q; Dai Y; Yao Y Toxicology; 2023 Dec; 500():153673. PubMed ID: 37979906 [TBL] [Abstract][Full Text] [Related]
30. Decreased Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942 [TBL] [Abstract][Full Text] [Related]
31. [Relationship between RAR-beta gene expression defect and its methylation]. Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338 [TBL] [Abstract][Full Text] [Related]
32. Upregulation of METTL14 mediates the elevation of PERP mRNA N Wang M; Liu J; Zhao Y; He R; Xu X; Guo X; Li X; Xu S; Miao J; Guo J; Zhang H; Gong J; Zhu F; Tian R; Shi C; Peng F; Feng Y; Yu S; Xie Y; Jiang J; Li M; Wei W; He C; Qin R Mol Cancer; 2020 Aug; 19(1):130. PubMed ID: 32843065 [TBL] [Abstract][Full Text] [Related]
33. m Takemoto S; Nakano M; Fukami T; Nakajima M Biochem Pharmacol; 2021 Nov; 193():114766. PubMed ID: 34536357 [TBL] [Abstract][Full Text] [Related]
34. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients. Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008 [TBL] [Abstract][Full Text] [Related]
35. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma. Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449 [TBL] [Abstract][Full Text] [Related]
36. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis. Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899 [TBL] [Abstract][Full Text] [Related]
37. HPV E6 promotes cell proliferation of cervical cancer cell by accelerating accumulation of RBM15 dependently of autophagy inhibition. Nie G; Tang B; Lv M; Li D; Li T; Ou R; Xu Y; Wen J Cell Biol Int; 2023 Aug; 47(8):1327-1343. PubMed ID: 37191290 [TBL] [Abstract][Full Text] [Related]
38. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells. Sathyanarayanan A; Chandrasekaran KS; Karunagaran D Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466 [TBL] [Abstract][Full Text] [Related]
39. Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer. Ralser DJ; Condic M; Klümper N; Ellinger J; Staerk C; Egger EK; Kristiansen G; Mustea A; Thiesler T J Cancer Res Clin Oncol; 2023 Jun; 149(6):2417-2424. PubMed ID: 35731272 [TBL] [Abstract][Full Text] [Related]
40. KCTD15 acts as an anti-tumor factor in colorectal cancer cells downstream of the demethylase FTO and the m6A reader YTHDF2. Zhang FY; Wu L; Zhang TN; Chen HH Commun Biol; 2024 Mar; 7(1):262. PubMed ID: 38438714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]